# Improving HIV assisted partner services outcomes by eliciting additional partners after the initial encounter

**Authors:** George Otieno, Sarah Masyuko, Unmesha Roy Paladhi, Edward Kariithi, Monisha Sharma, Hanley Kingston, Harison Lagat, David A. Katz, Beatrice Wamuti, Paul Macharia, Rose Bosire, Mary Mugambi, Bryan J. Weiner, Carey Farquhar

PMC · DOI: 10.1371/journal.pgph.0004406 · PLOS Global Public Health · 2026-02-03

## TL;DR

This study shows that continuing to ask HIV-positive individuals to name partners over 12 months leads to more new HIV diagnoses and identifies higher-risk partners compared to initial naming.

## Contribution

The study demonstrates the value of ongoing partner elicitation in assisted partner services for identifying new HIV cases and higher-risk behaviors.

## Key findings

- Partners named during follow-up visits were 3.9 times more likely to be newly diagnosed with HIV compared to those named initially.
- Follow-up partners were more likely to report high-risk behaviors like having multiple partners or partners at risk of HIV.
- Continuing partner elicitation increased the number of new HIV diagnoses and identified higher-risk partners.

## Abstract

Most assisted partner services (APS) programs elicit partners at the time of HIV diagnosis when index clients may be reluctant to name all partners. Little is known about the benefits of ongoing partner elicitation after the initial visit. We utilized data collected in an APS implementation study across 31 facilities in western Kenya from August 2019 to June 2022. HIV testing service providers offered APS to consenting female index clients and asked them to name their male partners both at initial diagnosis and during follow-up clinic visits for 12 months. Partners were traced and offered HIV testing. Using multivariable Poisson Generalized Estimated Equation models, we compared characteristics of index clients who did and did not name additional partners and assessed HIV diagnoses and characteristics of partners named during initial versus follow-up visits. The 872 female index clients who accepted APS named 3461 male partners, of whom 2920 (84%) were successfully contacted and HIV tested. Of 1819 male partners named at the initial visit, 430 (23.6%) were previously diagnosed and 90 (4.9%) were newly diagnosed with HIV. Of 1101 male partners named at follow-up visits, 335 (30.4%) were previously diagnosed and 193 (17.5%) were newly diagnosed with HIV. Among partners tested, those named at follow-up visits were 3.9 times more likely to be newly diagnosed with HIV than those named at the initial visit (Relative Risk = 3.88, 95%CI = 3.00–4.98) and were more likely to report behaviors associated with HIV transmission, including having sex with >1 partner (p < 0.001) and with a partner at risk of HIV or with unknown HIV status (p = 0.01). Continuing partner elicitation for APS for 12 months after the initial visit was associated with a higher likelihood of identifying male partners at increased HIV risk compared to those initially named and increased the number of new HIV diagnoses.

## Full-text entities

- **Genes:** SH2B2 (SH2B adaptor protein 2) [NCBI Gene 10603] {aka APS}
- **Diseases:** PLWH (MESH:C000719191), HIV (MESH:D015658), STI (MESH:D012749), AIDS (MESH:D000163), IPV (MESH:C563733)
- **Chemicals:** PEP (-), alcohol (MESH:D000438)
- **Species:** Human immunodeficiency virus 1 (no rank) [taxon 11676], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12867224/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12867224/full.md

## References

20 references — full list in the complete paper: https://tomesphere.com/paper/PMC12867224/full.md

---
Source: https://tomesphere.com/paper/PMC12867224